Compound genetically engineered mouse models of cancer reveal dual targeting of ALK1 and endoglin as a synergistic opportunity to impinge on angiogenic TGF-β signaling.
| Image |  |
|---|---|
| Description | scientific article published on 12 October 2016 |
| Author/s |
author: Matteo Bocci Kristian Pietras Nikolas M Eleftheriou Jonas Sjolund |
| Publication date | December 1, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |